SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivanza Biosciences informs about newspaper publication

22 Jul 2022 Evaluate
In terms of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Vivanza Biosciences has informed that it enclosed copy of newspaper advertisement published in English daily newspaper (Sunvilla Samachar) and one daily newspaper (Sunvilla Samachar) in Gujarati language of the region, where the registered office of the company is situated for extract of Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2022.

The above information is a part of company’s filings submitted to BSE.

Vivanza Biosciences Share Price

2.09 0.10 (5.03%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 220.95
Adani Enterprises 2088.20
Amrapali Industries 17.32
Rashi Peripheral 404.30
PDS 295.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×